Biocytogen’s Project Integrum Achieves Milestone Progress, Accelerating Antibody Business Growth
Business Wire India Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) announced today that its Project Integrum has completed 2 core milestones, and its antibody business is now entering a…